Dr. Rebecca Gladdy is a Surgeon Scientist and Associate Professor at the University of Toronto, who joined the faculty in 2008 after completing a Surgical Oncology Fellowship at Memorial Sloan-Kettering Cancer Center in New York. Her independent research program at the Lunenfeld-Tanenbaum Research Institute is focused on developing functional genomics platforms to inform the development of much-needed effective therapies for sarcoma patients. Her clinical expertise is in the surgical management of soft tissue sarcoma.
Dr. Gladdy is a member of the Sarcoma Program, which is the Centre of Excellence for Sarcoma Care in Canada and is affiliated with Princess Margaret Cancer Centre, Mount Sinai Hospital (MSH) and the Hospital for Sick Children. In addition to running a translational research lab, she is the Director of the GI Sarcoma Clinical Research Group at MSH, which is dedicated to advancing clinical care through engaging in clinical trials and improving quality of life for sarcoma patients.
Transatlantic Australasian Retroperitoneal Sarcoma Working Group 